655 related articles for article (PubMed ID: 15561796)
1. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
2. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
3. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
[TBL] [Abstract][Full Text] [Related]
4. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
[TBL] [Abstract][Full Text] [Related]
5. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
6. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
7. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
[TBL] [Abstract][Full Text] [Related]
8. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
Gergen KA; Zadina JE; Paul D
Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
Gergen KA; Zadina JE; Kastin AJ; Paul D
Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
[TBL] [Abstract][Full Text] [Related]
10. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
11. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
[TBL] [Abstract][Full Text] [Related]
13. Endomorphin analogues containing D-Pro2 discriminate different mu-opioid receptor mediated antinociception in mice.
Sakurada S; Watanabe H; Hayashi T; Yuhki M; Fujimura T; Murayama K; Sakurada C; Sakurada T
Br J Pharmacol; 2002 Dec; 137(8):1143-6. PubMed ID: 12466222
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
[TBL] [Abstract][Full Text] [Related]
16. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
17. Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission.
Mizoguchi H; Takagi H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2014 Jan; 51():15-25. PubMed ID: 24512946
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
19. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
Xie H; Woods JH; Traynor JR; Ko MC
Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
[TBL] [Abstract][Full Text] [Related]
20. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
